Taking Research to the Participant: Experiences with TREAT NOW, a No-Touch COVID-19 Trial
Abstract
Objective: Determine the effectiveness and safety of early treatment with lopinavir/ritonavir in outpatient adults with COVID-19: Adaptive, platform trial with ability to add (and remove) additional agents; Focus on (repurposed) FDA-approved, rapidly scalable/easily deployed therapies.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 31, 2022
- Accession Number
- AD1169532
Entities
People
- Adit Ginde
- Patrick C. Ng
- Vikhyat S Bebarta
Organizations
- 59th Medical Wing
- University of Colorado Boulder